This follows up on my article published last year: Hendlin YH, Han EL, Ling PM. Pharmaceuticalisation as the tobacco industry’s endgame. BMJ Global Health. 2024;9(2):e013866. doi:10.1136/bmjgh-2023-013866 discussing how “To revamp their image, Big Tobacco relies on two deceptive moves. First, they seek to decouple tobacco from nicotine – creating a false perception that non-tobacco nicotine products are less harmful. Next, they build on this lie to get around tobacco regulations with a host of “faux pharmaceutical” products – products they present to regulators as medical-grade tools to assist smokers wean off and eventually quit – yet as evidenced by the candy flavors and party imagery in their advertising, market to youth and young adults.”
